The relationship between magnesium deficiency and anxiety, the therapeutic effects of magnesium supplementation – literature review
DOI:
https://doi.org/10.12775/JEHS.2024.53.007Keywords
magnesium, deficiency, anxiety, supplementationAbstract
Introduction and purpose: The main aim of our study is to summarise existing knowledge and draw conclusions about the impact of magnesium deficiency on the occurrence of anxiety.
Methodology: The literature available in the National Library of Medicine database at https://pubmed.ncbi.nlm.nih.gov and Google Scholar was reviewed. Articles were searched by using keywords: magnesium, deficiency, supplementation, anxiety disorders. Forty-seven research papers and meta-analyses were analysed.
Description of the state of knowledge: Magnesium is an extremely important mineral in the human body involved in many physiological processes. A deficiency of this element affects the whole body and can cause mental disorders - including anxiety disorders. There are many theories showing a link between magnesium and anxiety disorders in both humans and animals. Magnesium has been shown to influence the function of neurotransmitters affecting the experience of anxiety. Supplementation in people with hypomagnesaemia has been proven to improve their health and well-being. However, it should be noted that supplements on the market vary in the bioavailability of the mineral, and the frequency of intake and dosage also affect the bioavailability of magnesium.
Conclusions: It is important to ensure adequate levels of magnesium in the diet, given its impact on the proper functioning of the human body (including the nervous system) and the fact that most people consume insufficient amounts of this macronutrient. Evidence of a link between magnesium levels and anxiety has led to increased interest in the potential efficacy of magnesium supplementation to alleviate anxiety symptoms.
References
de Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in man: implications for health and disease. Physiol Rev 2015; 95: 1-46.
Gröber U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients 2015; 7: 8199-8226.
Bancerz B, Duś-Żuchowska M, Cichy W, Matusiewicz H. Effect of magnesium on human health. Gastroenterol Rev 2012; 6: 359-366.
Szymczyk H. Magnesium - an element essential for the proper functioning of the body. Farm Współczesna 2016; 9: 217-223. Polish
Topf, J.M.; Murray, P.T. Hypomagnesemia and hypermagnesemia. Rev. Endocr. Metab. Disord. 2003, 42, 195–206
Karmańska A, Stańczak A, Karwowski B. Magnesium - current state of knowledge. Bromat Chem Toksykol. 2015;4:677-89. Polish
Zawadzka M, Pilarska E. Magnesium formulas in the treatment of migraine - a review of the literature. Neurologia dziecięca 2012;21:35-9. Polish
Jabłecka A, Korzeniowska K, Skołuda A, Cieślewicz A. Magnesium formulas Farm Współczesna 2011; 4: 29-32. Polish
Iskra M, Krasińska B, Tykarski A. Magnesium - physiological role, clinical significance of deficiency in hypertension and its complications, and possibilities for supplementation in the human body. Arter Hypertens 2013; 17: 447-459. Polish
Food and Nutrition Board, Institute of Medicine. Magnesium. dietary reference intakes: calcium, phosphorus, magnesium, vitamin D and fluoride. Washington D.C: National Academy Press; 1997. 190- 249
Kunachowicz H., Nadolna I., Przygoda B., Iwanow K., Tables of composition and nutritional value of foods, Wyd. 2, PZWL Wydawnictwo Lekarskie, Warszawa, 2017. Polish
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), Scientific opinion on Dietary Reference Values for magnesium, EFSA Journal, 2015, 13, 7, 4186.
Ilow R., Regulska-Ilow B., Różańska D. i wsp., Evaluation of mineral and vitamin intake in the diet of a sample of Polish population – baseline assessment from the prospective cohort ‘PONS’ study, Ann. Agric. Environ. Med., 2011, 18, 2, 235–240.
Hallak, M.; Berman, R.F.; Irtenkauf, S.M.; Evans, M.I.; Cotton, D.B. Peripheral Magnesium-Sulfate Enters the Brain and Increases the Threshold for Hippocampal Seizures in Rats. Am. J. Obstet. Gynecol. 1992, 1676, 1605–1610.
Cotton, D.B.; Hallak, M.; Janusz, C.; Irtenkauf, S.M.; Berman, R.F. Central Anticonvulsant Effects of Magnesium-Sulfate on N-Methyl-D-Aspartate Induced Seizures. Am. J. Obstet. Gynecol. 1993, 1683, 974–978.
Murck, H.; Steiger, A. Mg2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men—Possible therapeutic implications. Psychopharmacology 1998, 1373, 247–252.
Glynn, P.; Cooper, D.M.F.; Schulster, D. Modulation of Response of Bovine Adrenocortical Adenylate-Cyclase to Corticotropin. Biochem. J. 1977, 1682, 277–282.
Murck, H. Magnesium and affective disorders. Nutr. Neurosci. 2002, 56, 375–389.
Muroyama, A.; Inaka, M.; Matsushima, H.; Sugino, H.; Marunaka, Y.; Mitsumoto, Y. Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice. Neurosci. Res. 2009, 631, 72–75.
Singewald, N.; Sinner, C.; Hetzenauer, A.; Sartori, S.B.; Murck, H. Magnesium-deficient diet alters depressionand anxiety-related behavior in mice—Influence of desipramine and Hypericum perforatum extract. Neuropharmacology 2004, 478, 1189–1197.
Spasov, A.A.; Iezhitsa, I.N.; Kharitonova, M.V.; Kravchenko, M.S. Depression-like and anxiety-related behaviour of rats fed with magnesium-deficient diet. Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I P Pavlova 2008, 584, 476–485.
Whittle, N.; Li, L.; Chen, W.Q.; Yang, J.W.; Sartori, S.B.; Lubec, G.; Singewald, N. Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior. Amino Acids 2011, 404, 1231–1248.
Jacka, F.N.; Overland, S.; Stewart, R.; Tell, G.S.; Bjelland, I.; Mykletun, A. Association between magnesium intake and depression and anxiety in community-dwelling adults: The Hordaland Health Study. Aust. N. Z. J. Psychiatry 2009, 431, 45–52.
Barragan-Rodriguez, L.; Rodriguez-Moran, M.; Guerrero-Romero, F. Depressive symptoms and hypomagnesemia in older diabetic subjects. Arch. Med. Res. 2007, 387, 752–756.
Pavlinac, D.; Langer, R.; Lenhard, L.; Deftos, L. Magnesium in Affective-Disorders. Biol. Psychiatry 1979, 144, 657–661.
Chouinard, G.; Beauclair, L.; Geiser, R.; Etienne, P. A Pilot-Study of Magnesium Aspartate Hydrochloride (Magnesiocard) as a Mood Stabilizer for Rapid Cycling Bipolar Affective-Disorder Patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 1990, 142, 171–180.
Cox, I.M.; Campbell, M.J.; Dowson, D. Red-Blood-Cell Magnesium and Chronic Fatigue Syndrome. Lancet 1991, 3378744, 757–760.
Arzoz-Fabregas, M.; Ibarz-Servio, L.; Fernández-Castro, J.; Valiente-Malmagro, M.; Roca-Antonio, J.; Edo-Izquierdo, S.; Buisan-Rueda, O. Chronic stress and calcium oxalate stone disease: Influence on blood cortisol and urine composition. Urology 2013, 826, 1246–1252.
Kessler, R.C.; Aguilar-Gaxiola, S.; Alonso, J.; Chatterji, S.; Lee, S.; Ormel, J.; Ustün, T.B.; Wang, P.S. The global burden of mental disorders: An update from the WHO World Mental Health (WMH) surveys. Epidemiol. Psichiatr. Soc. 2009, 181, 23–33.
Sartori, S.B.; Whittle, N.; Hetzenauer, A.; Singewald, N. Magnesium deficiency induces anxiety and HPA axis dysregulation: Modulation by therapeutic drug treatment. Neuropharmacology 2012, 621, 304–312.
Pyndt Jørgensen, B.; Winther, G.; Kihl, P.; Nielsen, D.S.; Wegener, G.; Hansen, A.K.; Sørensen, D.B. Dietary magnesium deficiency affects gut microbiota and anxiety-like behaviour in C57BL/6N mice. Acta Neuropsychiatr. 2015, 2705, 307–311
Poleszak, E.; Szewczyk, B.; Kedzierska, E.; Wla ´z, P.; Pilc, A.; Nowak, G. Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol. Biochem. Behav. 2004, 78, 7–12.
Iezhitsa, I.N.; Spasov, A.A.; Kharitonova, M.V.; Kravchenko, M.S. Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, d-amphetamine, arecoline, nicotine, apomorphine, and L-5-hydroxytryptophan. Nutr. Neurosci. 2011, 141, 10–24.
Boyle NB, Lawton C, Dye L. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress – A Systematic Review. Nutrients. 2017; 9(5): 429
Siener R, Jahnen A, Hesse A. Bioavailability of magnesium from different pharmaceutical formulations.Urol Res. 2011; 39(2): 123–127
Schuchardt JP, Hahn A. Intestinal Absorption and Factors Influencing Bioavailability of Magnesium – An Update. Curr Nutr Food Sci. 2017; 13(4): 260–278
Grases, G.; Pérez-Castelló, J.A.; Sanchis, P.; Casero, A.; Perelló, J.; Isern, B.; Rigo, E.; Grases, F. Anxiety and stress among science students. Study of calcium and magnesium alterations. Magnes. Res. 2006, 192, 102–106
Held, K.; Antonijevic, I.A.; Künzel, H.; Uhr, M.; Wetter, T.C.; Golly, I.C.; Steiger, A.; Murck, H. Oral Mg2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry 2002, 354, 135–143
Johnson, P.L.; Shekhar, A. Panic-Prone State Induced in Rats with GABA Dysfunction in the Dorsomedial Hypothalamus Is Mediated by NMDA Receptors. J. Neurosci. 2006, 2626, 7093–7104.
Coan, E.J.; Collingridge, G.L. Magnesium ions block an N-methyl-D-aspartate receptor-mediated component of synaptic transmission in rat hippocampus. Neurosci. Lett. 1985, 53, 21–26.
Masugi, M.; Yokoi, M.; Shigemoto, R.; Muguruma, K.; Watanabe, Y.; Sansig, G.; van der Putten, H.; Nakanishi, S. Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion. J. Neurosci. 1999, 193, 955–963.
Niswender, C.M.; Conn, P.J. Metabotropic glutamate receptors: Physiology, pharmacology, and disease. Annu. Rev. Pharmacol. Toxicol. 2010, 50, 295–322.
Papadopol, V.; Nechifor, M. Magnesium in Neuroses and Neuroticism. In Magnesium and the Central Nervous System; Vink, R., Nechifor, M., Eds.; University of Adelaide Press: Adelaide, Australia, 2011.
Lydiard, R.B. The Role of GABA in Anxiety Disorders. J. Clin. Psychiatry 2003, 643, 21–27
Zhang X, Xia J, Del Gobbo LC i wsp. Serum magnesium concentrations and all-cause, cardiovascular, and cancer mortality among U.S. adults: Results from the NHANES I Epidemiologic Follow-up Study. Clin Nutr 2018; 37: 1541-1549.
Cuciureanu MD, Vink R. Magnesium and stress. W: Magnes. Vink R, Nechifor M (red.). Cent Nerv Syst, University of Adelaide Press 2011; 251-268.
Wojtasik A, Woźniak A, Stoś K, Jarosz M. Mineral components. Nutrition standards for the Polish population and their application. Jarosz M, Rychlik E, Stoś K, Charzewska J (red.). National Institute of Public Health - National Institute of Hygiene, Warszawa 2020; 273-282. Polish
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mateusz Rukat, Kinga Przyborowska, Justyna Kwiecień, Beata Getka, Katarzyna Wiejak, Michał Łata
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 518
Number of citations: 0